Copyright
©The Author(s) 2022.
World J Gastroenterol. Jan 14, 2022; 28(2): 230-241
Published online Jan 14, 2022. doi: 10.3748/wjg.v28.i2.230
Published online Jan 14, 2022. doi: 10.3748/wjg.v28.i2.230
Table 1 Characteristics of the study population
Cases, n = 110 | Controls, n = 252 | |||
n | Percent | n | Percent | |
Agea | ||||
mean | 63.2 | 12.7 | 54.5 | 11.8 |
Raceb | ||||
White | 102 | 96.2 | 186 | 85.7 |
Non-White | 4 | 3.8 | 31 | 14.3 |
Sexa | ||||
Female | 94 | 86.2 | 176 | 69.8 |
Male | 15 | 13.8 | 76 | 30.2 |
Marital status | ||||
Married | 75 | 70.8 | 146 | 66.7 |
Not married | 31 | 29.3 | 73 | 33.3 |
Educationa | ||||
Less than college | 36 | 34.0 | 122 | 55.7 |
College or postgrad | 70 | 66.0 | 97 | 44.3 |
Cigarette smokingc | ||||
Never smoker | 48 | 45.3 | 107 | 48.9 |
Former smoker | 46 | 43.4 | 66 | 30.1 |
Current smoker | 12 | 11.3 | 46 | 21.0 |
Irritable bowel syndromeb | ||||
Yes | 14 | 13.6 | 60 | 28.0 |
No | 89 | 86.4 | 154 | 72.0 |
Table 2 Body mass index and risk of microscopic colitis
Cases | Controls | |||||
n = 101 | n = 238 | Crude | Adjusted1 | |||
BMI | n | % | n | % | OR (95%CI) | aOR (95%CI) |
Overall | ||||||
< 25 | 50 | 49.5 | 73 | 30.7 | Ref. | Ref. |
25 < 30 | 29 | 28.7 | 60 | 25.2 | 0.71 (0.40-1.25) | 0.70 (0.37-1.31) |
≥ 30 | 22 | 21.8 | 105 | 44.1 | 0.31 (0.17-0.55) | 0.35 (0.18-0.66) |
Women | ||||||
< 25 | 47 | 53.4 | 47 | 28.7 | Ref. | Ref. |
25 -30 | 24 | 27.3 | 34 | 20.7 | 0.71 (0.36-1.37) | 0.67 (0.32-1.40) |
≥ 30 | 17 | 19.3 | 83 | 50.6 | 0.20 (0.10-0.40) | 0.21 (0.10-0.45) |
Men | ||||||
< 25 | 3 | 23.1 | 26 | 35.1 | Ref. | Ref. |
25 -30 | 5 | 38.5 | 26 | 35.1 | 1.67 (0.36-7.71) | 2.22 (0.41-12.05) |
≥ 30 | 5 | 38.5 | 22 | 29.7 | 1.97 (0.42-9.19) | 2.92 (0.52-16.22) |
Lost weight | ||||||
< 25 | 34 | 60.7 | 32 | 44.4 | Ref. | Ref. |
25 -30 | 13 | 23.2 | 17 | 23.6 | 0.72 (0.30-1.71) | 0.89 (0.35-2.22) |
≥ 30 | 9 | 16.1 | 23 | 31.9 | 0.37 (0.15-0.91) | 0.49 (0.19-1.28) |
No weight loss | ||||||
< 25 | 10 | 31.3 | 20 | 19.4 | Ref. | Ref. |
25 -30 | 13 | 40.6 | 30 | 29.1 | 0.87 (0.31-2.36) | 0.64 (0.20-2.04) |
≥ 30 | 9 | 28.1 | 53 | 51.5 | 0.33 (0.12-0.96) | 0.33 (0.10-1.11) |
IBS | ||||||
< 25 | 9 | 69.2 | 15 | 25.4 | Ref. | Ref. |
25-30 | 2 | 15.4 | 15 | 25.4 | 0.22 (0.04-1.21) | 0.26 (0.04-1.50) |
≥ 30 | 2 | 15.4 | 29 | 49.2 | 0.11 (0.02-0.60) | 0.13 (0.02-0.76) |
No IBS | ||||||
< 25 | 39 | 47.6 | 47 | 32.6 | Ref. | Ref. |
25 -30 | 26 | 31.7 | 37 | 25.7 | 0.85 (0.44-1.63) | 0.78 (0.39-1.58) |
≥ 30 | 17 | 20.7 | 60 | 41.7 | 0.34 (0.17-0.68) | 0.38 (0.18-0.79) |
Table 3 Reproductive factors and risk of microscopic colitis in women
Cases | Controls | ||||||
n = 94 | n = 176 | Crude | Model 11 | Model 22 | |||
n | % | n | % | OR (95%CI) | aOR (95%CI) | aOR (95%CI) | |
Age of menarche | |||||||
≤ 11 | 18 | 20.5 | 46 | 30.3 | Ref. | Ref. | Ref. |
12 | 24 | 27.3 | 36 | 23.7 | 1.70 (0.80-3.61) | 1.30 (0.53-3.17) | 1.41 0.52-3.83) |
13 | 23 | 26.1 | 38 | 25.0 | 1.55 (0.73-3.28) | 0.76 (0.31-1.85) | 0.54 (0.20-1.43) |
≥ 14 | 23 | 26.1 | 32 | 21.1 | 1.84 (0.86-3.94) | 0.90 (0.36-2.28) | 0.85 (0.30-2.42) |
Parity | |||||||
Nulliparous | 15 | 16.5 | 29 | 19.0 | Ref. | Ref. | Ref.3 |
Parous | 76 | 83.5 | 124 | 81.1 | 1.04 (0.88-1.24) | 1.02 (0.83-1.25) | 1.00 (0.81-1.23) |
Number of live births | |||||||
None | 15 | 16.5 | 29 | 19.0 | Ref. | Ref. | Ref.3 |
1 | 13 | 14.3 | 20 | 13.1 | 1.26 (0.49-3.20) | 1.16 (0.39-3.48) | 1.19 (0.40-3.60) |
2 | 42 | 46.2 | 60 | 39.2 | 1.35 (0.65-2.83) | 1.20 (0.50-2.89) | 1.15 (0.47-2.81) |
3 or more | 21 | 23.1 | 44 | 28.8 | 0.92 (0.41-2.08) | 0.78 (0.28-2.16) | 0.83-0.30-2.35) |
Age of first live birth (among parous women) | |||||||
≤ 19 | 13 | 17.1 | 32 | 25.8 | Ref. | Ref. | Ref. |
20-23 | 12 | 15.8 | 42 | 33.9 | 0.70 (0.28-1.75) | 0.24 (0.07-0.82) | 0.23 (0.07-0.85) |
24-29 | 26 | 34.2 | 27 | 21.8 | 2.37 (1.02-5.49) | 0.76 (0.24-2.43) | 0.78 (0.23-2.63) |
30+ | 25 | 32.9 | 23 | 18.6 | 2.68 (1.13-6.31) | 1.07 (0.32-3.58) | 1.02 (0.28-3.68) |
Oral contraceptives | |||||||
No | 27 | 29.7 | 23 | 15.0 | Ref. | Ref. | Ref. |
Yes | 64 | 70.3 | 130 | 85.0 | 0.42 (0.22-0.79) | 0.38 (0.17-0.84) | 0.20 (0.08-0.52) |
Table 4 Menopausal factors and risk of microscopic colitis in women
Cases | Controls | |||||
n = 94 | n = 176 | Crude | Adjusted | |||
n | % | n | % | OR (95%CI) | OR (95%CI)1 | |
Menopausal status | ||||||
Pre-menopausal | 13 | 14.4 | 40 | 26.1 | Ref. | Ref. |
Post-menopausal | 77 | 85.6 | 113 | 73.9 | 2.10 (1.05-4.18) | 1.20 (0.45-3.20) |
Age at menopause | ||||||
< 45 | 17 | 24.3 | 49 | 45.8 | 0.37 (0.19-0.74) | 0.64 (0.28-1.46) |
45-54 | 43 | 61.4 | 46 | 43.0 | Ref. | Ref. |
55+ | 10 | 14.3 | 12 | 11.2 | 0.89 (0.35-2.27) | 079 (0.28-2.22) |
Menopausal type | ||||||
Surgical | 31 | 40.3 | 70 | 62.0 | Ref. | Ref. |
Natural menopause | 46 | 59.7 | 43 | 38.1 | 0.41 (0.23-0.75) | 0.76 (0.37-1.54) |
Menopausal hormones2 | ||||||
No | 46 | 60.5 | 90 | 81.1 | Ref. | Ref. |
Ever | 30 | 39.5 | 21 | 18.9 | 2.80 (1.44-5.41) | 1.63 (0.73-3.62) |
Years Postmenopausal hormones2 | ||||||
None | 46 | 60.5 | 90 | 81.8 | Ref. | Ref. |
1-7 yr | 15 | 19.7 | 11 | 10 | 2.67 (1.13-6.28) | 1.65 (0.59-4.65) |
9+ yr | 15 | 19.7 | 9 | 8.2 | 3.26 (1.33-8.02) | 1.68 (0.60-4.73) |
- Citation: Sandler RS, Keku TO, Woosley JT, Sandler DP, Galanko JA, Peery AF. Obesity is associated with decreased risk of microscopic colitis in women. World J Gastroenterol 2022; 28(2): 230-241
- URL: https://www.wjgnet.com/1007-9327/full/v28/i2/230.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i2.230